Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies

Transfusion

Volumn 54, Issue 1, 2014, Pages 179-189

  Stowell, Sean R ^a   Girard Pierce, Kathryn R ^a   Smith, Nicole H ^a   Henry, Kate L ^a   Arthur, C Maridith ^a   Zimring, James C ^a   Hendrickson, Jeanne E ^a,b  

^a EMORY UNIVERSITY   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIGEN; DITHIOTHREITOL; ERYTHROCYTE ALLOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEL 1 ANTIGEN; KEL 2 ANTIGEN; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; BLOOD GROUP KELL SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFLAMMATION; MOUSE; NONHUMAN; PLASMA CLEARANCE; RECIPIENT; REPEAT PROCEDURE; WILD TYPE;

ANEMIA, HEMOLYTIC; ANIMALS; ANTIBODY FORMATION; BLOOD GROUP INCOMPATIBILITY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; INFLAMMATION; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLY I-C;

EID: 84891871753     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12217     Document Type: Article

References (46)

1. (FDA). Fatalities reported to the FDA following blood collection. 2012. [cited 2013 Feb 1]. Available from: URL: http://www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability
2. Moise KJ Jr, Argoti PS,. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012; 120: 1132-1139.
3. Reid ME, Mohandas N,. Red blood cell blood group antigens: structure and function. Semin Hematol 2004; 41: 93-117. (Pubitemid 38509637)
4. Reid ME, Lomas-Francis C,. The blood group antigen facts book. 2nd ed. Amsterdam: Elsevier Academic Press; 2004.
5. Brinc D, Denomme GA, Lazarus AH,. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models? Curr Opin Hematol 2009; 16: 488-496.
6. Kumpel BM,. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Transfusion 2006; 46: 1652-1656.
7. Kumpel BM,. Monoclonal anti-D development programme. Transpl Immunol 2002; 10: 199-204.
8. Kumpel BM,. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers. Vox Sang 2007; 93: 99-111. (Pubitemid 47228499)
9. Amos DB, Zumpft M, Armstrong P,. H-5.A and H-6.A, two mouse isoantigens on red cells and tissues detected serologically. Transplantation 1963; 1: 270-283.
10. Azen EA, Davisson MT, Cherry M, Taylor BA,. Prp (proline-rich protein) genes linked to markers Es-12 (esterase-12), Ea-10 (erythrocyte alloantigen), and loci on distal mouse chromosome 6. Genomics 1989; 5: 415-422.
11. Hod EA, Zimring JC, Spitalnik SL,. Lessons learned from mouse models of hemolytic transfusion reactions. Curr Opin Hematol 2008; 15: 601-605.
12. Zimring JC, Hendrickson JE,. The role of inflammation in alloimmunization to antigens on transfused red blood cells. Curr Opin Hematol 2008; 15: 631-635.
13. Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC,. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007; 110: 2736-2743. (Pubitemid 47523199)
14. Auffray I, Marfatia S, de Jong K, Lee G, Huang CH, Paszty C, Tanner MJ, Mohandas N, Chasis JA,. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001; 97: 2872-2878.
15. Smith NH, Hod EA, Spitalnik SL, Zimring JC, Hendrickson JE,. Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood 2012; 119: 1566-1569.
16. Campbell-Lee SA, Liu J, Velliquette RW, Halverson GR, Shirey RS, Chaudhuri A, Reid ME, Ness PM, Baldwin WM,. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Transfusion 2006; 46: 1682-1688. (Pubitemid 44435719)
17. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC,. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009; 114: 2315-2322.
18. Hendrickson JE, Hod EA, Spitalnik SL, Hillyer CD, Zimring JC,. Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion 2010; 50: 642-648.
19. Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, Roback JD,. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005; 106: 1105-1112. (Pubitemid 41076461)
20. Bao W, Yu J, Heck S, Yazdanbakhsh K,. Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 2009; 113: 5624-5627.
21. Schirmer DA, Song SC, Baliff JP, Harbers SO, Clynes RA, Krop-Watorek A, Halverson GR, Czerwinski M, Spitalnik SL,. Mouse models of IgG- and IgM-mediated hemolysis. Blood 2007; 109: 3099-3107. (Pubitemid 46482113)
22. Hod EA, Arinsburg SA, Francis RO, Hendrickson JE, Zimring JC, Spitalnik SL,. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang 2010; 99: 99-111.
23. Hod EA, Cadwell CM, Liepkalns JS, Zimring JC, Sokol SA, Schirmer DA, Jhang J, Spitalnik SL,. Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 2008; 112: 891-894.
24. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC,. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion 2012; 52: 2631-2645.
25. Coombs RR, Mourant AE, Race RR,. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946; 1: 264-266.
26. Ottensooser F, Mellone O, Blancalana A,. Fatal transfusion reaction due to the Kell factor. Blood 1953; 8: 1029-1033.
27. Westhoff CM, Reid ME,. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004; 20: 37-49. (Pubitemid 38292746)
28. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S,. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992; 79: 239-244.
29. Eder AF,. Update on HDFN: new information on long-standing controversies. Immunohematology 2006; 22: 188-195. (Pubitemid 46239723)
30. Moise KJ,. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008; 13: 207-214.
31. Rimon E, Peltz R, Gamzu R, Yagel S, Feldman B, Chayen B, Achiron R, Lipitz S,. Management of Kell isoimmunization-evaluation of a Doppler-guided approach. Ultrasound Obstet Gynecol 2006; 28: 814-820. (Pubitemid 44787468)
32. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA,. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798-803. (Pubitemid 28135986)
33. Vaughan JI, Warwick R, Welch CR, Letsky EA,. Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991; 98: 944-945.
34. Smith NH, Henry KL, Cadwell CM, Bennett A, Hendrickson JE, Frame T, Zimring JC,. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 2012; 52: 2620-2630.
35. Lee S, Russo DC, Pu J, Ho M, Redman CM,. The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function. Immunogenetics 2000; 52: 53-62. (Pubitemid 32803111)
36. Liepkalns JS, Cadwell CM, Stowell SR, Hod EA, Spitalnik SL, Zimring JC,. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion. Transfusion 2013; 53: 1319-1327.
37. Zimring JC, Cadwell CM, Chadwick TE, Spitalnik SL, Schirmer DA, Wu T, Parkos CA, Hillyer CD,. Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 2007; 110: 2201-2208. (Pubitemid 47443942)
38. Branch DR, Muensch HA, Sy Siok Hian AL, Petz LD,. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol 1983; 54: 573-578. (Pubitemid 13079072)
39. Tormey CA, Fisk J, Stack G,. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008; 48: 2069-2076.
40. Tormey CA, Stack G,. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009; 49: 505-512.
41. King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM,. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. [see comment]. Transfusion 1997; 37: 376-381. (Pubitemid 27193550)
42. Matzinger P,. The danger model: a renewed sense of self. Science 2002; 296: 301-305. (Pubitemid 34303674)
43. Hendrickson J, Roback JD, Hillyer CD, Easley KA, Zimring JC,. Discrete toll like receptor agonists have differential effects on alloimmunization to red blood cells. Transfusion 2008; 48: 1869-1877.
44. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC,. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006; 46: 1526-1536. (Pubitemid 44326328)
45. Beck ML, Marsh WL, Pierce SR, DiNapoli J, Oyen R, Nichols ME,. Auto anti-Kpb associated with weakened antigenicity in the Kell blood group system: a second example. Transfusion 1979; 19: 197-202. (Pubitemid 9235151)
46. Bosco A, Xenocostas A, Kinney J, Cadwell CM, Zimring JC,. An autoanti-Kp b immunoglobulin M that simulates antigen suppression. Transfusion 2009; 49: 750-756.